Peptide Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape
The global peptide therapeutics market is expected to grow at a CAGR of around 8.7% during 2025-2034. This report on global peptide therapeutics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global peptide therapeutics market by segmenting the market based on type, manufacturer, synthesis technology, routes of administration, application and region. Also, detailed profiles of companies operating in the peptide therapeutics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Rising Geriatric Population • Increasing Prevalence of Cancer • Technological Advancements
Market Challenges
• Poor Chemical and Physical Stability • Presence of Stringent Safety Regulations
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran United Arab Emirates Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Peptide Therapeutics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Peptide Therapeutics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Peptide Therapeutics Market by Type
5.1. Introduction
5.2. Innovative
5.3. Generic
6. Global Peptide Therapeutics Market by Type of Manufacturer
6.1. Introduction
6.2. Outsourced
6.3. In-house
7. Global Peptide Therapeutics Market by Synthesis Technology
7.1. Introduction
7.2. Solid Phase Peptide Synthesis
7.3. Liquid Phase Peptide Synthesis
7.4. Hybrid Technology
8. Global Peptide Therapeutics Market by Routes of Administration
8.1 Introduction
8.2 Parenteral
8.3 Oral
8.4 Others
9. Global Peptide Therapeutics Market Application
9.1. Gastrointestinal Disorders
9.2. Neurological Disorders
9.3. Metabolic Disorders
9.4. Cancer
9.5. Others
10. Global Peptide Therapeutics Market by Region
10.1 Introduction
10.2 Europe
10.2.1 Germany
10.2.2 United Kingdom
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Russia
10.2.7 Netherlands
10.2.8 Rest of the Europe
10.3 North America
10.3.1 United States
10.3.2 Canada
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 Indonesia
10.4.7 Rest of the Asia Pacific
10.5 Latin America
10.5.1 Mexico
10.5.2 Brazil
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 Turkey
10.6.3 Iran
10.6.4 United Arab Emirates
10.6.5 Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. Amgen Inc.
14.2.2. Apitope International NV
14.2.3. Arch Biopartners Inc.
14.2.4. AstraZeneca plc
14.2.5. Circle Pharma Inc.
14.2.6. Corden Pharma GmbH
14.2.7. F. Hoffmann-La Roche AG
14.2.8. Ipsen Group
14.2.9. Lonza Group AG
14.2.10. Novo Nordisk A/S
14.2.11. Pfizer Inc.
14.2.12. Teva Pharmaceuticals Industries Ltd.
14.2.13. Zealand Pharma A/S.
List of Figures
Figure 1: Global Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 2: Global Peptide Therapeutics Market by Type, 2024
Figure 3: Global Peptide Therapeutics Market by Manufacturer, 2024
Figure 4: Global Peptide Therapeutics Market by Synthesis Technology, 2024
Figure 5: Global Peptide Therapeutics Market by Routes of Administration, 2024
Figure 6: Global Peptide Therapeutics Market by Application, 2024
Figure 7: Global Peptide Therapeutics Market by Region, 2024
Figure 8: Global Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 9: Global Peptide Therapeutics Market by Type (in %), 2024 & 2034
Figure 10: Global Innovative Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 11: Global Innovative Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 12: Global Generic Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 13: Global Generic Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 14: Global Peptide Therapeutics Market by Manufacturer (in %), 2024 & 2034
Figure 15: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 16: Global Outsourced Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 17: Global In-house Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 18: Global In-house Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 19: Global Peptide Therapeutics Market by Synthesis Technology (in %), 2024 & 2034
Figure 20: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 21: Global Solid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 22: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 23: Global Liquid Phase Peptide Synthesis Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 24: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 25: Global Hybrid Technology Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 26: Global Peptide Therapeutics Market by Routes of Administration (in %), 2024 & 2034
Figure 27: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 28: Global Parenteral Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 29: Global Oral Peptide Therapeutics Market (in US$ Million), 2020-2024
Figure 30: Global Oral Peptide Therapeutics Market (in US$ Million), 2025-2034
Figure 31: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2020-2024
Figure 32: Global Other Routes of Administration Peptide Therapeutics Market(in US$ Million), 2025-2034
Figure 33: Global Peptide Therapeutics Market by Routes of Application (in %), 2024 & 2034